Send feedback

SHOC2 p.Ser57Phe

c.170C>T · rs536611911 · VCV179760

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 9 submitters
AlphaMissense
likely benign
0.1276 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0165%, mid)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
3
Cardiovascular phenotype

ClinGen expert panel — RASopathy VCEP

Uncertain Significance for RASopathy. Applied ACMG criteria (verbatim):

PP2

Curation rationale (ClinGen, verbatim)

The c.170C>T (p.Ser57Phe) variant in SHOC2 was present in 0.0055% (5/35376 CI 95%) of Latino alleles in gnomAD v2.1.1 (BS1 not met; PMID: 29493581). It has been identified in healthy individuals without clinical features of a RASopathy, but this information does not meet the current criteria to apply BS2 (Ambry Genetics internal data, Baylor Genetics internal data). The variant is located in SHOC2, which has been defined by the ClinGen RASopathy Expert Panel as a gene with a low rate of benign missense variants and pathogenic missense variants are common (PP2; PMID: 29493581). In summary, the clinical significance of the p.Ser57Phe variant is uncertain. RASopathy-specific ACMG/AMP criteria applied (PMID:29493581): PP2.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.1276likely benign
REVEL0.427indeterminate
SaProtLLR -9.30tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.7GERP 1.7, phastCons 1
Regional constrainto/e 0.83unconstrained · MANE · 376 bp · p 0.042 · regional, not allelic
Overall
CADD23.6PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0165% Middle Eastern · 1/6,062 alleles
Filtering AF 0.00773% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00579%
Overall 0.00539% 87/1,614,030 alleles · ultra-rare exomes 82/1,461,796 · genomes 5/152,234 · joint denominator
Ancestry group Frequency 1 in
Middle Easterngrpmax 0.0165% 6,062
Admixed American 0.015% 6,665
South Asian 0.00659% 15,181
Remaining individualsnot grpmax-eligible 0.0064% 15,627
European (non-Finnish) 0.00568% 17,612

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SHOC2
Protein
p.Ser57Phe
Coding
c.170C>T
MANE Select
NM_007373
dbSNP
rs536611911
Type
single nucleotide variant
Location
chr10:110964528 (GRCh38)
Gene constraint
LOEUF 0.201 · pLI 1.00 · ClinGen HI 0/3 (gnomAD)
Structure
AlphaFold pLDDT 88.00 · 13 PDB
Residue 57
the 'disordered' region
Full SHOC2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/shoc2-p-ser57phe (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown